Owari M, Harada-Shirado K, Togawa R,Fukatsu M, Sato Y, Fukuchi K, Endo M, Takahashi H, Kimura S, Osaki T, Souri M, Ichinose A, Shibata Y, Hashimoto Y, Ikezoe T Acquired von willebrand syndrome in a patient with multiple comorbidities, including MALT lymphoma with IgA monoclonal gammopathy and hyperviscosity syndrome Internal Medicine 62 (4), 605-611, 2023
Wada H, Kawasugi K, Honda G, Kawano N, Uchiyama T, Madoiwa S, Takezako N, Suzuki K, Seki Y, Ikezoe T, Iba T, Okamoto T Sepsis-associated DIC with decreased levels of antithrombin and fibrinogen is the target for combination therapy with thrombomodulin alfa and antithrombin TH Open 7 (1), e65-e75, 2023
Ikezoe T, Usuki K, Aida K, Hatayama T, Shirahase T, Yamauchi T Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment Cancer Science 114 (3), 1037-1044, 2023
Suzuki K, Ashutosh D Wechalekar, Kim K, Shimazaki C, Jin Seok Kim, Ikezoe T, Chang-Ki Min, Zhou F, Cai Z, Chen X, Iida S, Katoh N, Fujisaki T, Ho-Jin Shin, Tran NP, Qin X, Sandra Y Vasey, Brenda Tromp B, Brendan M Weiss, Raymond L Comenzo, Kastritis E, Lu J Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis:subgroup analysis of ANDROMEDA Annals of Hematology 102(4), 863-876, 2023
Onishi Y, Furukawa E, Kamata M, Fukatsu M, Kameoka Y, Hatta S, Hamada H, Oyake T, Kai T, Sukegawa M, Nakajima S, Yanagiya R, Yamaguchi K, Takahashi T, Harazaki Y, Izumi T, Murai K, Ito S, Ikezoe T, Ishizawa K, Takahashi N, Harigae H Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL. International Journal of Hematology 117(5), 738-747, 2023
Sano T, Ueda K, Minakawa K, Mori T, Hashimoto Y, Koseki H, Takeishi Y, Ikeda K, Ikezoe T Impaired repopulating ability of uhrf2-/- hematopoietic progenitor cells in mice. Genes 14(8), 1531-1545, 2023
Mori H, Harada-Shirado K, Kawano N, Hayakawa M, Seki Y, Uchiyama T, Yamakawa K, Ishikura H, Irie Y, Nishio K, Yada N, Okamoto K, Ikezoe T Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on Thrombosis and Haemostasis: a multicenter prospective cohort study. Thrombosis Journal 21 (1), 84, 2023
Usuki K, Ikezoe T, Ishiyama K, Kanda Y, Gotoh A, Hayashi H, Shimono A, Kitajima A, Obara N, Nishimura J Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan International Journal of Hematology 118 (3), 311-322, 2023
Hayashi K, Koyama D, Sato Y, Fukatsu M, Ikezoe T Lymphoplasmacytic lymphoma presenting cold agglutinin syndrome: Clonal expansion of KMT2D and IGHV4-34 mutations after COVID-19 British Journal of Haematology 203 (5), e110-e113, 2023
Fukuchi K, Koyama D, Mori H, Hayashi K, Asano N, Sato Y, Fukatsu M, Takano M, Takahashi H, Shirado-Harada K, Kimura S, Yamamoto T, Ikezoe T Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm International Journal of Hematology 118 (4), 489-493, 2023
Fukatsu M, Hamazaki Y, Sato Y, Koyama D, Ikezoe T A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D International Journal of Hematology 118(4), 472-476, 2023
Mori H, Koyama D, Sato Y, Kataoka Y, Taito S, Ishio T, Teshima T, Yokota I Prognostic value of hematogones in patients with hematopoietic disorders after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis Cureus 15(10), e47184, 2023
Sato Y, Fukatsu M, Suzuki T, Sasajima T, Gunji N, Yoshida S, Asano N, Fukuchi K, Mori H, Takano M, Hayashi K, Takahashi H, Shirado‑Harada K, Kimura S, Koyama D, Migita K, Ikezoe T Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation International Journal of Hematology 118 (5), 642-646, 2023
Okoshi C, Takahashi T, Fukatsu M, Suganuma R, Ikezoe T, Fujimori K A case of delayed postoperative bleeding after excision of endometrial polyp using resectoscope in an infertile woman with von Willebrand disease:a case report and literature review Fukushima Journal of Medical Science 69(3), 197-204, 2023
Izutsu K, Kumode T, Yuda J, Nagai H, Mishima Y, Suehiro Y, Yamamoto K, Fujisaki T, Ishitsuka K, Ishizawa K, Ikezoe T, Nishikori M, Akahane D, Fujita J, Dinh M, Soong D, Noguchi H, Jeppe Klint Buchbjerg, Favaro E, Fukuhara N Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma Cancer Science 114(12), 4643–4653, 2023
Ishiyama K, Yonemura Y, Kawaguchi T, Hosokawa K, Sugimori C, Ueda Y, Takamori H, Obara N, Noji H, Shirasugi Y, Ando K, Shichishima T, Ninomiya H, Chiba S, Nishimura J, Kanakura Y, Nakao S A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan British Journal of Haematology 203(3), 468-476, 2023
2023 Korean Society of Hematology International Conference & 64th Annual Meeting (2023.3.30-4.1, Seoul, Korea) Sawa M, Miyamoto T, Hee-Je Kim, Hiramatsu Y, June-Won Cheong, Ikezoe T, Naoe T, Akashi K, Morita S, Hasabou N, Heinloth A, Kosako M, Uemura E, Terada W, Kadokura T, Hill J,Miyawaki S Gilteritinib with Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia Blood Research, 58 (S1), 218-219, 2023
EHA2023 Hybrid Congress/The 28th European Hematology Association Congress (2023.6.8-6.11, Frankfurt, Germany) Ureshino H, Ueda Y, Fujisawa S, Usuki K, Tanaka H, Okada M, Kowata S, Murai K, Hirose A, Shindo M, Kumagai T, Nakao T,Takeoka T, Kamachi K, Kidoguchi K, Iyama S, Inamura J, Kobayashi T, Kawata E, Ohkawara H, Ikezoe T, Kimura S Allelic polymorphisms of kirs and HLAS predict favorable achievement of treatment-free remission in CML: results from the pokstic trial, multicenter retrospective observational study HemaSphere, 7 (S3), 1181-1182, 2023
ISTH2023 CONGRESS (2023.6.24-6.28, Montreal, Canada) Hayashi K, Koyama D, Hamazaki Y, Kamiyama T, Yamada S, Tanino Y, Shibata Y, Ikezoe T Intracellular nuclear proteins histone H3 and HMGB1 are predictive markers of disease severity and prognosis of COVID-19 patients
65TH ASH ANNUAL MEETING AND EXPOSITION (2023.12.09-12.12, California, America) Ikezoe T, Tachibana T, Hata C, Cai-Xia Wang, Koyama D, Oriuchi N, Nishijima K, Ukon N, Shimoyama S, Joho T, Washiyama K, Takahashi K, Zhao S Delivery of α-particles by a human-rat chimeric CD82 monoclonal antibody potently inhibits the proliferation of CD82-expressing acute myeloid leukemia cells in a murine xenograft model Blood, 142(Supplement 1), 2794, 2023
学会発表 - 国内総会 - 一般演題
65TH ASH ANNUAL MEETING AND EXPOSITION (2023.12.09-12.12, California, America) Hosono N, Yamauchi T, Sung-Gi C, Arai H, Fukushima K, Ikeda D, Iyama S, Gotoh A, Ikezoe T, Yoshida C, Yoshimoto G, Kanda J, Takahashi N, Sakaida E, Usuki K, Minami Y Practical and flexible genome profiling study using the Halo-shape annealing and defer-ligation enrichment (HANDLE) system: HM-Screen-JAPAN02 Blood, 142(Supplement 1), 2279, 2023
65TH ASH ANNUAL MEETING AND EXPOSITION (2023.12.09-12.12, California, America) Daver N, Joshua F. Zeidner, Yuda J, Justin M. Watts, Mark J. Levis, Fukushima K, Ikezoe T, Ogawa Y, Brandwein J, Eunice S. Wang, Miyazaki Y, Timothy S Pardee, Hosono N, Shima T, Yokoyama H, Asada N, Jurcic J, Cai H, Watanabe A, Hitron M, Brooks E, Xu B, Shah J, Hagop M. Kantarjian, Harry P. Erba Phase 1/2 first-in-human study of the menin-MLL inhibitor DSP-5336 in patients with relapsed or refractory acute leukemia Blood, 142(Supplement 1), 2911, 2023
65TH ASH ANNUAL MEETING AND EXPOSITION (2023.12.09-12.12, California, America) Ureshino H, Takahashi N, Ikezoe T, Takamori A, Kawaguchi A, Ichinohe T, Kimura S Lower-initiating dose of bosutinib for resistant or intolerant to prior therapy chronic myeloid leukemia patients (BOGI trial): a single-arm, multicenter, phase II trial Blood, 142(Supplement 1), 3179, 2023
International Seminar of Genetic Diseases for Young Physicians and Researchers, 2023 (2023.8.4, 東京) 池添隆之 An adult case of ASMD type B diagnosed with thrombocytopenia and hepatosplenomegaly
第10回日本アミロイドーシス学会学術集会(2023.9.23, 高知) Takayuki Ikezoe Cardiac amyloid reaching for extended survival (CARES) trials: 2 placebo-controlled, double－blind, randomized, phase 3 trials assessing CAEL-101 in patients with mayo stages IIIA/IIIB al amyloidosis
第45回日本血栓止血学会学術集会(2023.6.15-6.17, 福岡) 林 清人, 小山大輔, 濱崎洋一, 神山隆道, 山田晋吾, 谷野功典, 柴田陽光, 池添隆之 Syndecan-1 as a predicter of severity and prognosis in COVID-19 patients
